Organisational unit: Research group

Research areas and keywords

UKÄ subject classification

  • Neurosciences
  • Neurology


Our research aims at developing new restorative and neuroprotective treatments for neurodegenerative diseases using cell transplantation and direct in vivo gene delivery. The Neurobiology Unit seeks to develop techniques for isolation and identification of neural progenitor cells with the capacity to generate fully functional dopamine neurons after transplantation to the Parkinsonian brain.


We use cell sorting and cell engineering techniques to generate dopamine neuron precursor cells specifically for transplantation purposes, and explore techniques for insertion of genes into stem cells to direct the development of stem cells into transplantable midbrain dopamine neurons. In a second line of research we explore rodent models of Parkinson´s disease to study the mechanisms underlying development of L-DOPA-induced dyskinesias, and use recombinant viral vectors as tools to model Parkinson-like neurodegeneration in rodents, and for delivery of putative therapeutic factors, GDNF and Nurr 1 in particular, to the brain.

Recent research outputs

David Mengel, Shorena Janelidze, Robert J. Glynn, Wen Liu, Oskar Hansson & Dominic M. Walsh, 2020 Nov 1, In: Annals of Neurology. 88, 5, p. 878-892 15 p.

Research output: Contribution to journalArticle

Natalie Andersson, Bjorn Bakker, Jenny Karlsson, Anders Valind, Linda Holmquist Mengelbier, Diana C J Spierings, Floris Foijer & David Gisselsson, 2020 Apr, In: Cancer Research. 80, 7, p. 1512-1523 12 p.

Research output: Contribution to journalArticle

Antoine Leuzy, Johan Lilja, Christopher J. Buckley, Rik Ossenkoppele, Sebastian Palmqvist, Mark Battle, Gill Farrar, Dietmar R. Thal, Shorena Janelidze, Erik Stomrud, Olof Strandberg, Ruben Smith & Oskar Hansson, 2020, In: Neurology. 95, 21, p. e2834-e2844

Research output: Contribution to journalArticle

View All (341)